ATE154036T1 - Retrovirale protease-inhibitoren - Google Patents

Retrovirale protease-inhibitoren

Info

Publication number
ATE154036T1
ATE154036T1 AT92870021T AT92870021T ATE154036T1 AT E154036 T1 ATE154036 T1 AT E154036T1 AT 92870021 T AT92870021 T AT 92870021T AT 92870021 T AT92870021 T AT 92870021T AT E154036 T1 ATE154036 T1 AT E154036T1
Authority
AT
Austria
Prior art keywords
protease inhibitors
retroviral protease
protease
retroviral
coch2
Prior art date
Application number
AT92870021T
Other languages
English (en)
Inventor
Garland Ross Marshall
Mihaly Vadkerti Toth
Original Assignee
Univ Washington
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Washington filed Critical Univ Washington
Application granted granted Critical
Publication of ATE154036T1 publication Critical patent/ATE154036T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/02—Linear peptides containing at least one abnormal peptide link
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/16011—Human Immunodeficiency Virus, HIV
    • C12N2740/16211—Human Immunodeficiency Virus, HIV concerning HIV gagpol
    • C12N2740/16222—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Virology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Oncology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Communicable Diseases (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • AIDS & HIV (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AT92870021T 1991-02-07 1992-02-06 Retrovirale protease-inhibitoren ATE154036T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/652,163 US5086165A (en) 1989-03-08 1991-02-07 Inhibitors of retroviral protease with a ketomethylene isosteric replaced amide bond

Publications (1)

Publication Number Publication Date
ATE154036T1 true ATE154036T1 (de) 1997-06-15

Family

ID=24615760

Family Applications (1)

Application Number Title Priority Date Filing Date
AT92870021T ATE154036T1 (de) 1991-02-07 1992-02-06 Retrovirale protease-inhibitoren

Country Status (7)

Country Link
US (1) US5086165A (de)
EP (1) EP0498784B1 (de)
JP (1) JPH0565230A (de)
AT (1) ATE154036T1 (de)
CA (1) CA2060785A1 (de)
DE (1) DE69220100T2 (de)
DK (1) DK0498784T3 (de)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5554728A (en) * 1991-07-23 1996-09-10 Nexstar Pharmaceuticals, Inc. Lipid conjugates of therapeutic peptides and protease inhibitors
US6071895A (en) * 1992-03-11 2000-06-06 Narhex Limited Polar-substituted hydrocarbons
US5888992A (en) * 1992-03-11 1999-03-30 Narhex Limited Polar substituted hydrocarbons
JPH07504654A (ja) * 1992-03-11 1995-05-25 ナルヘックス　リミテッド オキソ及びヒドロキシ置換炭化水素のアミン誘導体
MXPA93002392A (es) 1992-03-11 2005-02-04 Narhex Ltd Derivados amino de hidrocarburos-oxo e hidroxi-substituidos.
CA2091151A1 (en) * 1992-03-13 1993-09-14 Kwan Y. Hui Retroviral protease inhibitors
US5364961A (en) * 1992-06-15 1994-11-15 Monsanto Company Process for making optically active α-amino ketones
US5559256A (en) * 1992-07-20 1996-09-24 E. R. Squibb & Sons, Inc. Aminediol protease inhibitors
US5473092A (en) * 1992-11-20 1995-12-05 Monsanto Company Synthesis of optically-active phosphono analogs of succinates
IL111991A (en) * 1994-01-28 2000-07-26 Abbott Lab Liquid pharmaceutical composition of HIV protease inhibitors in organic solvent
US6222043B1 (en) 1995-06-30 2001-04-24 Japan Energy Corporation Methods of preparing novel dipeptide compounds or pharmaceutically acceptable salts thereof
US5932550A (en) * 1995-06-30 1999-08-03 Japan Energy Corporation Dipeptide compound or pharmaceutically acceptable salt thereof and medical use thereof
US5872210A (en) * 1995-10-05 1999-02-16 The United States Of America As Represented By The Department Of Health And Human Services Transframe peptide inhibitor of viral protease
US5747526A (en) * 1996-01-25 1998-05-05 Hollinshead; Ariel C. Anti-HIV /Aids Chemo(C)-, immuno(I)-, or ci-therapy using tur (or related compounds) and/or NVA (or EPV)
US6291432B1 (en) 1996-12-27 2001-09-18 Japan Energy Corporation Tripeptide compounds and anti-AIDS medicine
US7141593B1 (en) * 1999-06-04 2006-11-28 Abbott Laboratories Pharmaceutical formulations

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4880779A (en) * 1987-07-31 1989-11-14 Research Corporation Technologies, Inc. Method of prevention or treatment of AIDS by inhibition of human immunodeficiency virus
US5342922A (en) * 1989-03-08 1994-08-30 Washington University Inhibitors of retroviral protease

Also Published As

Publication number Publication date
JPH0565230A (ja) 1993-03-19
DK0498784T3 (da) 1997-10-27
EP0498784A3 (en) 1993-03-31
EP0498784A2 (de) 1992-08-12
US5086165A (en) 1992-02-04
DE69220100D1 (de) 1997-07-10
EP0498784B1 (de) 1997-06-04
CA2060785A1 (en) 1992-08-08
DE69220100T2 (de) 1998-01-02

Similar Documents

Publication Publication Date Title
DK0387231T3 (da) Hidtil ukendte inhibitorer for retroviral protease
ATE154036T1 (de) Retrovirale protease-inhibitoren
DK0774971T3 (da) Syntetiske peptid-inhibitorer for HIV-overförsel
ATE377006T1 (de) Aus d-aminosäuren abgeleitete cystein- und serinproteasehemmer
EA199700221A1 (ru) Замещенный аминокислотой гидроксиэтиламиносульфонамид в качестве ингибиторов ретровирусной протеазы
DE69434817D1 (de) Protease varianten
EA199700239A1 (ru) Ингибиторы тромбина, основанные на аминокислотной последовательности гирудина
DK0792287T3 (da) Peptidanaloger af humant basisk myelinprotein
BR9500732B8 (pt) Kit diagnóstico para a detecção de anticorpos contra vírus que causam imunodeficiência.
DK3688D0 (da) Pankreatisk sekretorisk trypsininhibitor og varianter deraf fremstillet af en rekombinant vaert, fremgangsmaade, ekspressionsvektor og rekombinant vaert samt farmaceutisk anvendelse deraf
ATE309264T1 (de) Peptidyl-2-amino-1hydroxyalkansulfonsäuren als cystein-protease-inhibitoren
NO914158D0 (no) En ny protease
DE69715181D1 (de) Peptid der löslichen form von acetylcholinesterase mit aktivität als calciumkanalmodulator
ATE24917T1 (de) Peptide-derivate, deren herstellung und verwendung als elastasehemmende mittel.
ATE146188T1 (de) Substituierungsanaloge von magaininpeptiden
ATE211719T1 (de) Korrosionsinhibitoren enthaltender injektionszement
ES539382A0 (es) Procedimiento para la determinacion de fibrina
ES2083387T3 (es) Peptidos sinteticos y sus mezclas para la deteccion de anticuerpos hiv.
DK450187D0 (da) Fremgangsmaade til fremstilling af proteiner
DE69133166D1 (de) Inhibitoren von katalytischen antikörpern
ES2023746A6 (es) Procedimiento de preparacion de peptidos de serina-acido aspartico- lisina

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee